E

Erie County Medical Center | Department of Medical Oncology

Research site
(Unclaimed)
Location
462 Grider Street, Buffalo, New York, United States of America
Site insights

Top conditions

Hypertension (4 trials)

Infections (4 trials)

Depressive Disorder (3 trials)

Depression (3 trials)

Kidney Diseases (3 trials)

Top treatments

Buprenorphine
Aticaprant
Dexamethasone
Inclacumab
Prednisone
Empagliflozin
albuterol
Lurasidone HCl
Darunavir
beclamethasone dipropionate

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

10 of 54
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
A Study of AAV2-hAQP1 Gene Therapy in Participants With Radiation-Induced Late Xerostomia (AQUAX2)

This study will assess the efficacy and safety of bilateral intra-parotid administration of AAV2-hAQP1 in adults with Grade 2 or Grade 3 radiation-in...

Enrolling
Grade 2 and 3 Late Xerostomia Caused by Radiotherapy for Cancers of the Upper Aerodigestive Tract, Excluding the Parotid Glands
Other: Placebo
Genetic: AAV2-hAQP1 Concentration 2

The purpose of this study is to evaluate the efficacy of aticaprant compared with placebo as adjunctive therapy to an antidepressant in improving dep...

Enrolling
Depressive Disorder, Major
Anhedonia
Other: Placebo
Drug: Aticaprant

The purpose of this study is to assess the long-term safety and tolerability of aticaprant administered as adjunctive therapy to a current antidepres...

Enrolling
Depressive Disorder, Major
Drug: Aticaprant
Locations recently updated

The main purpose of this study is to assess the efficacy and safety of Tirzepatide (LY3298176) in participants with heart failure with preserved ejec...

Active, not recruiting
Heart Failure With Preserved Ejection Fraction (HFpEF)
Obesity
Other: Placebo
Drug: Tirzepatide

This Phase 3 study will assess the safety and efficacy of inclacumab, a P-selectin inhibitor, in reducing the frequency of vaso-occlusive crises (VOC...

Active, not recruiting
Vaso-occlusive Crisis
Vaso-occlusive Pain Episode in Sickle Cell Disease
Drug: Placebo
Drug: Inclacumab

The purpose of this study is to compare the efficacy and safety of mezigdomide (CC-92480), bortezomib and dexamethasone (MeziVd) versus pomalidomide,...

Enrolling
Relapsed or Refractory Multiple Myeloma
Drug: Dexamethasone
Drug: Pomalidomide

This is a prospective, multicenter, randomized, double-blind, placebo-controlled, parallel-group, large simple trial to investigate the efficacy and...

Enrolling
Traumatic Injury
Drug: BE1116
Drug: Placebo
Locations recently updated

This study is to evaluate the long-term safety, efficacy and tolerability of lorundrostat (an aldosterone synthase inhibitor) in subjects with uncont...

Enrolling
Hypertension
Drug: lorundrostat
Drug: Placebo

The purpose of this study is to evaluate the long-term safety and tolerability of cariprazine in the treatment of pediatric participants with schizop...

Enrolling
Bipolar I Disorder
Schizophrenia
Drug: Cariprazine Flexible Dose

The overall purpose of this clinical study is to evaluate safety and efficacy of the MuReva Phototherapy System with a light delivery mouthpiece to r...

Enrolling
Oral Mucositis (Ulcerative) Due to Radiation
Oral Mucositis (Ulcerative)
Other: Routine Oral Care and Analgesia
Device: Photobiomodulation

Trial sponsors

University at Buffalo (UB) logo

University at Buffalo (UB) (10 trials)

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems